Literature DB >> 27594540

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).

Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen, Željko Reiner, Gabriele Riccardi, Marja-Riita Taskinen, Lale Tokgozoglu, W M Monique Verschuren, Charalambos Vlachopoulos, David A Wood, Jose Luis Zamorano.   

Abstract

Entities:  

Keywords:  apolipoprotein B; cholesterol; dyslipidaemias; high-density lipoproteins; lipoprotein remnants; low-density lipoproteins; total cardiovascular risk; treatment, adherence; treatment, drugs; treatment, lifestyle; triglycerides

Mesh：

Year:  2016        PMID： 27594540     DOI： 10.1016/j.atherosclerosis.2016.08.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  203 in total

Review 1.  Cholesterol Management in the Era of PCSK9 Inhibitors.

Authors:  Anna Svatikova; Stephen L Kopecky
Journal:  Curr Cardiol Rep       Date:  2017-09       Impact factor: 2.931

Review 2.  A clinical prescription for heart health in midlife women.

Authors:  Chrisandra Shufelt; Erika Dutra; Tina Torbati; Tina Ramineni
Journal:  Maturitas       Date:  2018-11-12       Impact factor: 4.342

3.  Family Physician-Led Group Visits for Lifestyle Modification in Women with Weight Problems: A Pilot Intervention and Follow-Up Study.

Authors:  Merthan Tunay; Hatice Kurdak; Sevgi Özcan; Çiğdem Özdemir; Zeliha Yelda Özer
Journal:  Obes Facts       Date:  2018-02-07       Impact factor: 3.942

4.  Therapeutic effects of statins on chromosomal DNA damage of dyslipidemic patients.

Authors:  Hamiyet Donmez-Altuntas; Fahri Bayram; Ayse N Coskun-Demirkalp; Osman Baspınar; Derya Kocer; Peter P Toth
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-19

5.  [Seeking Ariadne's thread in the labyrinth of guidelines].

Authors:  R Dörr; B Maisch
Journal:  Herz       Date:  2016-12       Impact factor: 1.443

6.  PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.

Authors:  Maciej Banach; Piotr Jankowski; Jacek Jóźwiak; Barbara Cybulska; Adam Windak; Tomasz Guzik; Artur Mamcarz; Marlena Broncel; Tomasz Tomasik; Jacek Rysz; Agnieszka Jankowska-Zduńczyk; Piotr Hoffman; Agnieszka Mastalerz-Migas
Journal:  Arch Med Sci       Date:  2016-12-19       Impact factor: 3.318

7.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

Review 8.  Guest Editorial: Reducing Risk in Familial Hypercholesterolaemia and Severe Dyslipidaemia: Novel Drugs Targeting PCSK9.

Authors:  Antonio J Vallejo-Vaz
Journal:  Eur Cardiol       Date:  2018-08

9.  Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.

Authors:  Najmeh Ahangari; Mohammad Doosti; Majid Ghayour Mobarhan; Amirhossein Sahebkar; Gordon A Ferns; Alireza Pasdar
Journal:  Ann Med       Date:  2020-08-24       Impact factor: 4.709

10.  Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study - preliminary results.

Authors:  Karolina Obońska; Michał Kasprzak; Kamila Tymosiak; Tomasz Fabiszak; Magdalena Krintus; Jacek Kubica
Journal:  Cardiol J       Date:  2020-11-17       Impact factor: 2.737
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.